Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:48:59 UTC |
---|
HMDB ID | HMDB0000030 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Biotin |
---|
Description | Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as coenzyme R and vitamin H or B7. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Humans fulfill their biotin requirement through their diet through endogenous reutilization of biotin and perhaps through the capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss, and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC), and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signalling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signalling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signalling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to the effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signalling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology (PMID: 15992684 , 16011464 ). |
---|
Structure | [H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2 InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid | ChEBI | (3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid | ChEBI | 5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid | ChEBI | Biotina | ChEBI | Biotine | ChEBI | Biotinum | ChEBI | cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid | ChEBI | cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid | ChEBI | cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid | ChEBI | Coenzyme R | ChEBI | D-(+)-Biotin | ChEBI | D-Biotin | ChEBI | Vitamin b7 | ChEBI | Vitamin H | ChEBI | Bioepiderm | Kegg | (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valerate | Generator | (3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valerate | Generator | 5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoate | Generator | cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valerate | Generator | cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valerate | Generator | cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valerate | Generator | (+)-Biotin | HMDB | -(+)-Biotin | HMDB | 1SWK | HMDB | 1SWN | HMDB | 1SWR | HMDB | Biodermatin | HMDB | Bios H | HMDB | Bios II | HMDB | D(+)-Biotin | HMDB | D-Biotin factor S | HMDB | delta-(+)-Biotin | HMDB | delta-Biotin | HMDB | delta-Biotin factor S | HMDB | Factor S | HMDB | Factor S (vitamin) | HMDB | Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoate | HMDB | Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoic acid | HMDB | Hexahydro-2-oxo-[3as-(3aa,4b,6aa)]-1H-thieno[3,4-D]imidazole-4-pentanoate | HMDB | Hexahydro-2-oxo-[3as-(3aa,4b,6aa)]-1H-thieno[3,4-D]imidazole-4-pentanoic acid | HMDB | Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-thieno[3,4-D]imidazole-4-pentanoate | HMDB | Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-thieno[3,4-D]imidazole-4-pentanoic acid | HMDB | Lutavit H2 | HMDB | Meribin | HMDB | Rovimix H 2 | HMDB | Vitamin-H | HMDB | Biotin hermes brand | HMDB | Biotin roche brand | HMDB | Biotin simons brand | HMDB | Biotin strathmann brand | HMDB | Biotin ziethen brand | HMDB | Biotin ratiopharm | HMDB | Roche brand OF biotin | HMDB | Roche, biotine | HMDB | E+b pharma brand OF biotin | HMDB | Medobiotin | HMDB | Biokur | HMDB | Biotinratiopharm | HMDB | Gelfert, biotin | HMDB | Hermes brand OF biotin | HMDB | Hermes, biotin | HMDB | Medopharm brand OF biotin | HMDB | Ratiopharm brand OF biotin | HMDB | Biocur brand OF biotin | HMDB | Biotin dermapharm brand | HMDB | Biotine roche | HMDB | Deacura | HMDB | Dermapharm brand OF biotin | HMDB | Gabunat | HMDB | Medebiotin | HMDB | Rombellin | HMDB | Ziethen brand OF biotin | HMDB | Biotin biocur brand | HMDB | Biotin gelfert | HMDB | Biotin hermes | HMDB | Biotin medopharm brand | HMDB | Biotin ratiopharm brand | HMDB | Biotin-ratiopharm | HMDB | H, Vitamin | HMDB | Medea brand OF biotin sodium salt | HMDB | Simons brand OF biotin | HMDB | Strathmann brand OF biotin | HMDB |
|
---|
Chemical Formula | C10H16N2O3S |
---|
Average Molecular Weight | 244.311 |
---|
Monoisotopic Molecular Weight | 244.088163078 |
---|
IUPAC Name | 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid |
---|
Traditional Name | 5-[(3aS,4S,6aR)-2-oxo-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid |
---|
CAS Registry Number | 58-85-5 |
---|
SMILES | [H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2 |
---|
InChI Identifier | InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1 |
---|
InChI Key | YBJHBAHKTGYVGT-ZKWXMUAHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as biotin and derivatives. These are organic compounds containing a ureido (tetrahydroimidizalone) ring fused with a tetrahydrothiophene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Biotin and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Biotin and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Biotin
- Imidazolyl carboxylic acid derivative
- Medium-chain fatty acid
- Heterocyclic fatty acid
- Thia fatty acid
- Fatty acid
- Fatty acyl
- Thiolane
- 2-imidazoline
- Isourea
- Azacycle
- Dialkylthioether
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Carboxylic acid derivative
- Thioether
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organopnictogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 232 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.22 mg/mL at 25 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Biotin,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 | 2520.5 | Semi standard non polar | 33892256 | Biotin,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)N[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2546.8 | Semi standard non polar | 33892256 | Biotin,1TMS,isomer #3 | C[Si](C)(C)N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 | 2539.2 | Semi standard non polar | 33892256 | Biotin,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C | 2580.1 | Semi standard non polar | 33892256 | Biotin,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C | 2306.2 | Standard non polar | 33892256 | Biotin,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C | 4188.6 | Standard polar | 33892256 | Biotin,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C)[C@H]12 | 2568.5 | Semi standard non polar | 33892256 | Biotin,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C)[C@H]12 | 2298.2 | Standard non polar | 33892256 | Biotin,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C)[C@H]12 | 4247.6 | Standard polar | 33892256 | Biotin,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)N([Si](C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2481.3 | Semi standard non polar | 33892256 | Biotin,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)N([Si](C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2311.0 | Standard non polar | 33892256 | Biotin,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)N([Si](C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 3326.8 | Standard polar | 33892256 | Biotin,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C)C(=O)N2[Si](C)(C)C | 2459.9 | Semi standard non polar | 33892256 | Biotin,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C)C(=O)N2[Si](C)(C)C | 2378.7 | Standard non polar | 33892256 | Biotin,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C)C(=O)N2[Si](C)(C)C | 2983.0 | Standard polar | 33892256 | Biotin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 | 2759.9 | Semi standard non polar | 33892256 | Biotin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)N[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2768.2 | Semi standard non polar | 33892256 | Biotin,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 | 2758.9 | Semi standard non polar | 33892256 | Biotin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C(C)(C)C | 3055.6 | Semi standard non polar | 33892256 | Biotin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C(C)(C)C | 2787.2 | Standard non polar | 33892256 | Biotin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2[Si](C)(C)C(C)(C)C | 3987.0 | Standard polar | 33892256 | Biotin,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C(C)(C)C)[C@H]12 | 3049.0 | Semi standard non polar | 33892256 | Biotin,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C(C)(C)C)[C@H]12 | 2779.6 | Standard non polar | 33892256 | Biotin,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N([Si](C)(C)C(C)(C)C)[C@H]12 | 4008.6 | Standard polar | 33892256 | Biotin,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)N([Si](C)(C)C(C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2897.2 | Semi standard non polar | 33892256 | Biotin,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)N([Si](C)(C)C(C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 2819.9 | Standard non polar | 33892256 | Biotin,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)N([Si](C)(C)C(C)(C)C)[C@H]2CS[C@@H](CCCCC(=O)O)[C@H]21 | 3231.0 | Standard polar | 33892256 | Biotin,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C | 3112.9 | Semi standard non polar | 33892256 | Biotin,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C | 3053.8 | Standard non polar | 33892256 | Biotin,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C | 3092.8 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Biotin GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-0f76-1960000000-b21ddd69490cac3254f8 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Biotin GC-MS (3 TMS) | splash10-0f76-3960000000-a8a94e2de123f66979d8 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Biotin GC-EI-TOF (Non-derivatized) | splash10-0f76-1960000000-b21ddd69490cac3254f8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Biotin GC-MS (Non-derivatized) | splash10-0f76-3960000000-a8a94e2de123f66979d8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-6910000000-11bfe0a5a77f7dfaa8c5 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (1 TMS) - 70eV, Positive | splash10-00dl-9680000000-eb01d8147a82f7982b54 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Biotin GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-01pt-9500000000-a1e1ec56cf32236ac6b1 | 2018-05-25 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-0006-0090000000-6d956bb533d353d449c9 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-0006-0190000000-01f67d1bdf8c742e48c8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0fxx-3920000000-f0b9613cbd9371e4be92 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-9400000000-107f2a44f521c2513578 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0006-9000000000-1a3f65d909dc40055e87 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positive-QTOF | splash10-004i-0090000000-c928e8d0a18f3f848262 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positive-QTOF | splash10-066s-1920000000-5f795e0b7f1d7cf986e5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positive-QTOF | splash10-0ar1-1920000000-c298be862857cb3bbc7f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positive-QTOF | splash10-000t-0900000000-cdc4a4c359ff765fd32d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-qTof , Positive-QTOF | splash10-05xs-1920000000-3be430b63e9c748c681a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QTOF , negative-QTOF | splash10-0006-0090000000-bcffb0dcf77e8fd727a4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QTOF , negative-QTOF | splash10-0f6x-0390000000-c209523d36e9a7681f44 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ , negative-QTOF | splash10-0006-0090000000-c0f81ee86772310db415 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ , negative-QTOF | splash10-0006-0190000000-016eb89528e564c74720 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ , negative-QTOF | splash10-0fxx-3920000000-f0b9613cbd9371e4be92 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ , negative-QTOF | splash10-0006-9400000000-107f2a44f521c2513578 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-d08e1b3709844e1e91b0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin LC-ESI-ITFT , negative-QTOF | splash10-0006-0190000000-21d0f2512788276bbb89 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Biotin Linear Ion Trap , negative-QTOF | splash10-0udj-0690000000-dc372934024e58bdcc60 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 10V, Positive-QTOF | splash10-002b-0290000000-43932f104dea28cbdfb8 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 20V, Positive-QTOF | splash10-0002-1960000000-d3673c6bc624b97f35be | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 40V, Positive-QTOF | splash10-052f-9600000000-00a4e152d89024a9b423 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 10V, Negative-QTOF | splash10-0006-1390000000-3f4b512cfa57b894ff94 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 20V, Negative-QTOF | splash10-0f6y-7890000000-ea1e647fc5b31e42af0b | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Biotin 40V, Negative-QTOF | splash10-0006-9100000000-e139c928dcc46b225bdb | 2016-09-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Mitochondria
- Nucleus
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0034 (0.002 - 0.0051) uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0016 (0.0009 - 0.0028) uM | Children (1-13 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.0024 (0.0008 - 0.0041) uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.11-0.13 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00127 +/- 0.00067 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000557 +/- 0.000307 uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0005 +/- 0.0002 uM | Adult (>18 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.123 +/- 0.141 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.071 +/- 0.041 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.296 +/- 0.150 uM | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.014 (0.002-0.044) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.049 +/- 0.035 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.023 (0.013-0.032) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.08198 (0.00033-0.421) uM | Not Specified | Not Specified | Acute lymphoblastic leukemia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.16 uM | Not Specified | Not Specified | Bronchopulmonary dysplasia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00039 uM | Not Specified | Not Specified | Burkitt's lymphoma | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000447 +/- 0.000217 uM | Not Specified | Not Specified | Dementia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000336 +/- 0.00008603 uM | Not Specified | Not Specified | Epilepsy | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0229 uM | Not Specified | Not Specified | Head injury | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0273 (0.0247-0.0299) uM | Not Specified | Not Specified | Lymphoblastic lymphoma | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000545 (0.00004799-0.00192) uM | Not Specified | Not Specified | Motor neuron disease (MND) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000324 +/- 0.000107 uM | Not Specified | Not Specified | Multiple sclerosis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000692 +/- 0.000602 uM | Not Specified | Not Specified | Polyneuropathy | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000438 +/- 0.000156 uM | Not Specified | Not Specified | Vascular encephalopathies | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 58.242 +/- 21.921 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Acute Lymphoblastic Leukemia |
---|
- Bogusiewicz A, Stratton SL, Ellison DA, Mock DM: Biotin accounts for less than half of all biotin and biotin metabolites in the cerebrospinal fluid of children. Am J Clin Nutr. 2008 Nov;88(5):1291-6. [PubMed:18996865 ]
| Dementia |
---|
- Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92. [PubMed:10577274 ]
| Epilepsy |
---|
- Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92. [PubMed:10577274 ]
| Head injury |
---|
- Bogusiewicz A, Stratton SL, Ellison DA, Mock DM: Biotin accounts for less than half of all biotin and biotin metabolites in the cerebrospinal fluid of children. Am J Clin Nutr. 2008 Nov;88(5):1291-6. [PubMed:18996865 ]
| Motor neuron disease |
---|
- Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92. [PubMed:10577274 ]
| Multiple sclerosis |
---|
- Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92. [PubMed:10577274 ]
| Colorectal cancer |
---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB00121 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB014510 |
---|
KNApSAcK ID | C00000756 |
---|
Chemspider ID | 149962 |
---|
KEGG Compound ID | C00120 |
---|
BioCyc ID | BIOTIN |
---|
BiGG ID | 33931 |
---|
Wikipedia Link | Biotin |
---|
METLIN ID | 243 |
---|
PubChem Compound | 171548 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 15956 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | BTN |
---|
MarkerDB ID | MDB00000015 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Corey, E. J.; Mehrotra, Mukund M. A simple and enantioselective synthesis of (+)-biotin. Tetrahedron Letters (1988), 29(1), 57-60. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Thuy LP, Belmont J, Nyhan WL: Prenatal diagnosis and treatment of holocarboxylase synthetase deficiency. Prenat Diagn. 1999 Feb;19(2):108-12. [PubMed:10215065 ]
- Zempleni J, McCormick DB, Mock DM: Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine. Am J Clin Nutr. 1997 Feb;65(2):508-11. [PubMed:9022537 ]
- Bussolati G, Gugliotta P, Volante M, Pace M, Papotti M: Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology. 1997 Nov;31(5):400-7. [PubMed:9416479 ]
- Mock DM, Stadler DD, Stratton SL, Mock NI: Biotin status assessed longitudinally in pregnant women. J Nutr. 1997 May;127(5):710-6. [PubMed:9164991 ]
- Thuy LP, Sweetman L, Nyhan WL: A new immunochemical assay for biotin. Clin Chim Acta. 1991 Oct 31;202(3):191-7. [PubMed:1814646 ]
- Limat A, Suormala T, Hunziker T, Waelti ER, Braathen LR, Baumgartner R: Proliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotin. Arch Dermatol Res. 1996;288(1):31-8. [PubMed:8750932 ]
- Bigham SL, Ballard JD, Giles KD, Clelland CS, Jeffcoat R, Griffin KS, Farley TD, Bushman DR, Wright JR: Synthesis and possible applications of biotin-linked copper clusters. Physiol Chem Phys Med NMR. 1990;22(2):63-72. [PubMed:2100006 ]
- Mock DM, Stadler DD: Conflicting indicators of biotin status from a cross-sectional study of normal pregnancy. J Am Coll Nutr. 1997 Jun;16(3):252-7. [PubMed:9176832 ]
- Bingham JP, Bian S, Tan ZY, Takacs Z, Moczydlowski E: Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-activated K+ channel expressed in a human cell line. Bioconjug Chem. 2006 May-Jun;17(3):689-99. [PubMed:16704206 ]
- Mock DM: Biotin status: which are valid indicators and how do we know? J Nutr. 1999 Feb;129(2S Suppl):498S-503S. [PubMed:10064317 ]
- Mock DM, Dyken ME: Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology. 1997 Nov;49(5):1444-7. [PubMed:9371938 ]
- Mock DM, Nyalala JO, Raguseo RM: A direct streptavidin-binding assay does not accurately quantitate biotin in human urine. J Nutr. 2001 Aug;131(8):2208-14. [PubMed:11481419 ]
- Mardach R, Zempleni J, Wolf B, Cannon MJ, Jennings ML, Cress S, Boylan J, Roth S, Cederbaum S, Mock DM: Biotin dependency due to a defect in biotin transport. J Clin Invest. 2002 Jun;109(12):1617-23. [PubMed:12070309 ]
- Mock DM, Heird GM: Urinary biotin analogs increase in humans during chronic supplementation: the analogs are biotin metabolites. Am J Physiol. 1997 Jan;272(1 Pt 1):E83-5. [PubMed:9038855 ]
- Fujimoto W, Inaoki M, Fukui T, Inoue Y, Kuhara T: Biotin deficiency in an infant fed with amino acid formula. J Dermatol. 2005 Apr;32(4):256-61. [PubMed:15863846 ]
- Schenker S, Hu ZQ, Johnson RF, Yang Y, Frosto T, Elliott BD, Henderson GI, Mock DM: Human placental biotin transport: normal characteristics and effect of ethanol. Alcohol Clin Exp Res. 1993 Jun;17(3):566-75. [PubMed:8333586 ]
- Mock NI, Malik MI, Stumbo PJ, Bishop WP, Mock DM: Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency. Am J Clin Nutr. 1997 Apr;65(4):951-8. [PubMed:9094878 ]
- Grafe F, Wohlrab W, Neubert RH, Brandsch M: Transport of biotin in human keratinocytes. J Invest Dermatol. 2003 Mar;120(3):428-33. [PubMed:12603856 ]
- Gravel RA, Narang MA: Molecular genetics of biotin metabolism: old vitamin, new science. J Nutr Biochem. 2005 Jul;16(7):428-31. [PubMed:15992684 ]
- Zempleni J: Uptake, localization, and noncarboxylase roles of biotin. Annu Rev Nutr. 2005;25:175-96. [PubMed:16011464 ]
- Holmberg A, Blomstergren A, Nord O, Lukacs M, Lundeberg J, Uhlen M: The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis. 2005 Feb;26(3):501-10. [PubMed:15690449 ]
|
---|